Bioventus Q2 Adjusted EBITDA USD 35.3 Million
BVS•Bioventus reports Q2 sales below estimate
Aug. 5 (Reuters) - Bioventus Q2 sales were USD 153.2 million versus the IBES estimate of USD 155.6 million.
BVS•Aug. 5 (Reuters) - Bioventus Q2 sales were USD 153.2 million versus the IBES estimate of USD 155.6 million.
